{"schema_version":"secwatch.filing_event.v1","accession":"0000883984-24-000040","form_type":"8-K","ticker":"ICUI","cik":"0000883984","company_name":"ICU MEDICAL INC/DE","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.253412+00:00","generated_at":"2026-05-30T02:33:52.664166+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ICU Medical Q3 2024 revenue up 6.5% to $589.1M; GAAP net loss $33M, adj EPS $1.59","bullets":["Revenue $589.1M vs $553.3M YoY; GAAP gross margin improved to 34.8% from 33.2%.","GAAP net loss $(33.0)M ($1.35 per diluted share) vs net income $7.2M ($0.30) in Q3 2023.","Adjusted diluted EPS $1.59 vs $1.57 YoY; Adjusted EBITDA $94.8M vs $89.8M.","Company updated FY2024 guidance; specific guidance numbers not fully disclosed in excerpt."],"urls":{"canonical":"https://secwatch.observer/filing/0000883984-24-000040","json":"https://secwatch.observer/filing/0000883984-24-000040.json","markdown":"https://secwatch.observer/filing/0000883984-24-000040.md","text":"https://secwatch.observer/filing/0000883984-24-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000040/0000883984-24-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/883984/000088398424000040/icui-20241112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:33:52.664166+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}